BRASILIA (Reuters) - Brazil’s Health Ministry said in a statement on Tuesday that the country would purchase the Pfizer COVID-19 vaccine after it is proven safe in clinical trials and registered with the domestic health regulator.
The statement followed a meeting between Brazil health officials and Pfizer. The pharmaceutical company said last week that the vaccine being developed in partnership with BioNTech was more than 90% effective, citing preliminary data.
Reporting by Ricardo Brito, writing by Jake Spring, Editing by Rosalba O’Brien
Our Standards: The Thomson Reuters Trust Principles.